Biglycan anticorps (C-Term)
Aperçu rapide pour Biglycan anticorps (C-Term) (ABIN375174)
Antigène
Voir toutes Biglycan (BGN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- C-DRLAIQFGNY KK
-
Specificité
- This antibody recognizes Biglycan Preproprotein.
-
Réactivité croisée (Details)
-
Species reactivity (expected):Mouse, Canine.
Species reactivity (tested):Human, Rat. -
Purification
- Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide
-
Immunogène
- Synthetic peptide from the C-Terminus of Human Biglycan (NP_001702.1) Genename: BGN
-
-
-
-
Indications d'application
-
Peptide ELISA: 1/8000. Western Blot: 0.1 - 0.3 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, pH ~7.3, 0.02 % Sodium Azide, 0.5 % BSA
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Biglycan (BGN)
-
Autre désignation
- Biglycan
-
Sujet
- Biglycan is an extracellular matrix proteoglycan that is closely related in structure to decorin and fibromodulin. Biglycan and decorin are thought to be the result of a gene duplication. Biglycan is expressed in secondary myotubes during fetal muscle formation. In adult muscle it is located in the endomysium and neuromuscular junctions, where it connects to the dystrophin-associated proteins through binding to a-dystroglycan. In developing newborn mice biglycan expression is initially high and then decreases during skeletal muscle differentiation and maturation. Biglycan may also have a role in the fibrotic process since it is overexpressed in atherosclerotic lesions and has been shown to cause an increase in thymidine incorporation and migration of vascular smooth muscle cells.Synonyms: BGN, Bone/cartilage proteoglycan I, PG-S1, PGS1, SLRR1A, Small Leucine-rich Protein 1A
-
Poids moléculaire
- 41.7 kDa (Human NP_001702.1 and Rat NP_058783.1)
-
ID gène
- 633
-
NCBI Accession
- NP_001702
-
UniProt
- P21810
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-